member
larg
famili
carcinoembryon
antigen
protein
primarili
type
transmembran
protein
multipl
splice
variant
though
solubl
form
also
exist
wide
express
varieti
tissu
includ
endothelium
epithelium
hematopoiet
cell
hematolog
solid
tumor
interact
homophil
heterophil
fashion
physiolog
pathogenassoci
ligand
includ
carcinoembryon
antigen
neisseria
spp
protein
isoform
contain
intracellular
itim
motif
activ
result
recruit
phosphatas
dephosphoryl
substrat
across
rang
signal
pathway
thu
inhibit
cell
receptor
tcr
signal
suppress
multipl
aspect
cell
function
agonist
attenu
cytokin
secret
cell
polar
cytolyt
function
vivo
ligat
solubl
ligand
overexpress
itimcontain
isoform
cell
attenu
experiment
coliti
addit
also
express
intestin
cell
patient
celiac
diseas
ulcer
coliti
may
repres
attempt
immun
system
neg
regul
inflammatori
process
addit
immun
regul
exert
wide
varieti
biolog
function
cellcel
adhes
molecul
receptor
varieti
commens
pathogen
microb
mous
man
also
regul
angiogenesi
energi
homeostasi
tumor
biolog
regul
tumorigenesi
colon
cancer
prognost
factor
lung
adenocarcinoma
tumor
express
may
regul
tumor
angiogenesi
invas
express
cea
tumor
may
inhibit
function
tumor
infiltr
lymphocyt
allobmt
establish
therapi
cur
intent
varieti
hematolog
malign
nonmalign
condit
alloreact
cell
donor
origin
play
critici
role
gvhd
major
complic
allobmt
graftversustumor
activ
major
contributor
efficaci
allobmt
cancer
therapi
donorrecipi
antigen
dispar
donor
cell
tissu
injuri
result
inflamm
due
condit
regimen
contribut
gvhd
primarili
affect
intestin
liver
skin
thymu
express
leukocyt
especi
cell
well
epitheli
endotheli
cell
promin
compon
parenchyma
abovement
gvhd
target
organ
addit
upregul
mani
tumor
report
assess
impact
alloreact
cell
donor
allograft
well
effect
defici
recipi
allobmt
respect
gvhd
gvt
activ
assess
regul
ghvd
donor
cell
recipi
two
welldescrib
major
histocompat
complex
mhc
class
iiidispar
model
use
mice
tg
mice
describ
figur
balbc
mice
sourc
donor
cell
recipi
experi
recipi
receiv
splitdos
lethal
irradi
balbc
gy
gy
graft
allogen
cell
deplet
bone
marrow
tcdbm
wildtyp
wt
origin
without
splenic
cell
first
transplant
irradi
balbc
mice
tcdbm
wt
cell
observ
recipi
cell
significantli
increas
mortal
compar
recipi
wt
cell
figur
left
confirm
second
mhcdispar
allobmt
model
figur
right
next
ask
whether
cell
overexpress
would
caus
less
diseas
transplant
balbc
recipi
donor
wt
ceacam
cell
dose
recipi
cell
show
attenu
mortal
figur
final
assess
role
tissu
allobmt
recipi
transfer
tcdbmt
cell
wt
vs
balbc
recipi
reveal
recipi
increas
earli
overal
mortal
nearli
mice
succumb
within
first
week
figur
next
ask
whether
regul
gvhd
target
organ
damag
assess
effect
defici
overexpress
donor
cell
allobmt
recipi
observ
recipi
cell
sever
larg
intestin
gvhd
figur
surprisingli
howev
mice
exhibit
less
thymic
gvhd
determin
thymic
cellular
number
doubleposit
dp
thymocyt
figur
thymic
cellular
agesexmatch
nontranspl
anim
shown
figur
also
observ
modest
trend
toward
less
skin
gvhd
recipi
cell
figur
suggest
cell
caus
preferenti
damag
larg
intestin
experi
compar
recipi
wt
cell
day
posttranspl
found
recipi
cell
demonstr
significantli
less
gvhd
liver
intestin
thymu
compar
recipi
wt
cell
similar
skin
gvhd
figur
appear
suggest
cell
caus
less
gvhd
overal
rel
littl
organ
specif
final
assess
allobmt
recipi
day
posttranspl
correspond
increas
earli
gvhd
mortal
allobmt
recipi
show
increas
larg
bowel
damag
thymic
gvhd
figur
next
assess
number
donor
effector
cell
transfer
cellcontain
allograft
allobmt
recipi
compar
recipi
wt
cell
receiv
cell
observ
increas
number
donor
alloactiv
effector
cell
spleen
mln
iel
allobmt
recipi
figur
associ
concomit
decreas
number
alloactiv
cell
pln
liver
analyz
organ
recipi
allograft
contain
wt
vs
cell
note
decreas
number
donor
effector
cell
mln
pln
liver
figur
via
histopatholog
analysi
also
observ
decreas
number
total
lymphocyt
infiltr
liver
small
larg
bowel
histopatholog
figur
well
decreas
neutrophil
infiltr
organ
data
shown
final
assess
infiltr
cell
wt
allobmt
recipi
observ
increas
number
donor
alloactiv
effector
cell
mln
iel
allobmt
recipi
decreas
number
cell
pln
liver
figur
acceler
earli
mortal
allobmt
recipi
togeth
increas
accumul
donor
cell
gi
tract
mesenter
lymph
node
decreas
number
peripher
lymph
node
figur
led
us
ask
whether
differenti
effect
regul
gvhd
target
organ
damag
variou
target
organ
tissu
context
recipi
therefor
test
radiat
sensit
mice
use
host
irradi
wt
balbc
mice
assess
surviv
anim
show
increas
kinet
mortal
case
overal
mortal
radiat
injuri
figur
similar
result
obtain
background
figur
enumer
regener
surviv
crypt
small
intestin
termin
ileum
hour
irradi
assess
intestin
radiat
damag
observ
mice
fewer
regener
surviv
crypt
compar
wt
counterpart
figur
indic
greater
damag
small
intestin
across
wide
rang
radiat
dose
thu
quit
like
radiationcontain
condit
regimen
transplant
recipi
also
contribut
part
surviv
kinet
select
gvhd
target
organ
damag
figur
select
accumul
donor
cell
lymphoid
tissu
target
organ
figur
recipi
next
studi
varieti
possibl
mechan
may
regul
donor
cell
function
analyz
donor
wt
alloactiv
splenic
cell
day
allobmt
traffick
molecul
found
effector
cell
express
higher
level
integrin
subunit
gut
home
integrin
figur
import
intestin
gvhd
howev
wt
vs
effector
cell
similar
integrin
subunit
express
yet
also
accumul
greater
number
gut
figur
suggest
regul
target
organ
damag
like
involv
multipl
addit
mechan
beyond
traffick
molecul
express
addit
level
subunit
form
integrin
similar
level
data
shown
assess
express
traffick
molecul
recipi
wt
vs
cell
allograft
found
signific
differ
level
subunit
integrin
figur
molecul
consist
system
reduct
gvhd
recipi
cell
final
assess
traffick
molecul
irradi
wt
vs
recipi
ident
donor
allograft
observ
donor
splenic
cell
recipi
trend
toward
increas
express
subunit
although
directli
reflect
increas
express
integrin
figur
taken
togeth
observ
suggest
regul
traffick
molecul
express
one
compon
regul
gvhd
target
organ
damag
found
activ
cell
thu
perform
kinet
analysi
express
cell
alloactiv
adopt
transfer
cfselabel
cell
irradi
balbc
recipi
observ
transient
express
day
alloactiv
figur
data
shown
furthermor
cfselo
alloactiv
cell
divid
time
hour
express
low
consist
detect
level
figur
kinet
consist
role
regul
earli
event
cell
alloactiv
express
alloreact
cell
adopt
transfer
occur
vivo
similar
kinet
cell
alloactiv
ask
whether
either
donor
alloreact
cell
radioresist
cell
allobmt
recipi
could
regul
process
transfer
cfselabel
purifi
wt
splenic
cell
irradi
balbc
recipi
analyz
donor
cell
spleen
day
observ
rel
isotyp
control
stain
increas
percentag
alloactiv
cfselo
cell
posit
alloactiv
marker
greater
percentag
cell
downregul
wt
cell
figur
suggest
becam
activ
addit
increas
percentag
donor
cell
divid
cfselo
alloactiv
state
figur
suggest
enhanc
prolifer
absenc
repeat
experi
alloreact
cell
expect
observ
decreas
number
cfselo
cell
assess
cfse
dilut
figur
consist
inhibitori
role
prolifer
alloreact
cell
howev
observ
signific
differ
alloactiv
vs
wt
donor
cell
data
shown
lastli
assess
role
express
radioresist
cell
allobmt
recipi
donor
cell
alloactiv
transfer
cfselabel
cell
irradi
wt
vs
balbc
mice
analyz
donor
cell
spleen
day
observ
differ
prolifer
data
shown
donor
cell
allogen
recipi
exhibit
increas
alloactiv
measur
figur
measur
serum
cytokin
recipi
wt
cell
day
posttranspl
observ
level
tnf
similar
data
shown
percentag
donor
regulatori
cell
express
tbet
also
similar
recipi
wt
cell
data
shown
tabl
stimul
splenocyt
harvest
day
bmt
posttranspl
three
group
reveal
essenti
donor
cell
shown
similar
percentag
donor
cell
data
shown
tabl
regul
cytolyt
respons
lymphocyt
assess
cytolyt
function
wt
vs
alloactiv
cell
spleen
allobmt
recipi
day
cell
wt
cell
demonstr
similar
cytolysi
allogen
b
cell
lymphoma
cell
control
tabl
lastli
found
differ
dc
number
activ
state
mhc
class
ii
infus
cell
tabl
allobmt
recipi
final
assess
gvt
activ
donor
alloreact
cell
lymphoma
renca
renal
cell
carcinoma
recipi
donor
cell
improv
surviv
lymphoma
model
figur
cell
replet
group
show
compar
surviv
renca
solid
tumor
model
figur
analyz
two
tumor
line
express
note
lymphoma
cell
uniformli
express
high
level
subset
renca
cell
express
figur
report
show
found
donor
alloreact
cell
well
nonhematopoiet
tissu
gastrointestin
hepat
epithelium
regul
donor
cell
function
sensit
allobmt
recipi
radiationcontain
prepar
regimen
addit
donor
cell
tumor
may
modul
gvt
activ
donor
allograft
recipi
tissu
thu
appear
repres
import
regul
gvhd
gvt
morbid
mortal
via
cell
depend
independ
mechan
suggest
therapeut
approach
modul
may
need
assess
balanc
gvhd
vs
gvt
cell
previous
shown
restrain
cell
polar
cytokin
secret
cytotox
gvhd
model
system
howev
found
similar
cell
polar
cytokin
secret
analyz
donor
alloreact
cell
ex
vivo
tabl
ascrib
strongli
proinflammatori
cytokin
milieu
found
recipi
follow
myeloabl
radiat
treatment
well
ubiquit
presenc
alloantigen
togeth
promot
strong
differenti
regardless
express
howev
model
system
regul
cell
activ
number
donor
alloactiv
cell
lymphoid
tissu
gvhd
target
tissu
pattern
gener
correl
level
target
organ
damag
figur
also
assess
role
allobmt
recipi
model
system
wt
cell
environ
show
phenotyp
similar
cell
show
increas
activ
select
damag
larg
intestin
preferenti
accumul
mln
intestin
parenchyma
mice
gvhd
correspondingli
decreas
infiltr
liver
pln
ultim
lead
exacerb
diseas
acceler
mortal
first
two
week
posttranspl
suggest
donor
cell
interact
recipi
tissu
fratern
interact
cell
donor
graft
suffici
restrain
gvhd
recipi
howev
increas
earli
mortal
allobmt
recipi
gvhd
also
led
us
ask
whether
mice
sensit
radiat
injuri
mice
significantli
defect
hematopoiesi
subleth
irradi
gy
data
shown
exhibit
significantli
increas
damag
small
intestin
lethal
irradi
figur
also
directli
regul
intestin
epithelia
due
enhanc
signal
jejun
ileal
enterocyt
exhibit
higher
level
posit
cell
cycl
regul
cmyc
cyclin
dysregul
cmyc
may
sensit
cell
apoptosi
higher
level
protein
may
render
enterocyt
sensit
radiat
injuri
final
also
regul
cellcel
adhes
normal
patholog
condit
may
therefor
also
possibl
loss
regul
radiationinduc
slough
intestin
epithelium
difficult
directli
assess
rel
import
gastrointestin
radiat
sensit
versu
increas
gvhd
allobmt
recipi
radiationinduc
gut
damag
may
directli
manifest
intestin
patholog
yet
transmur
migrat
bacteri
superantigen
import
first
step
initi
gvhd
increas
damag
intestin
mice
may
thu
amplifi
develop
gvhd
mice
also
explain
part
specif
increas
larg
intestin
gvhd
observ
experi
donor
cell
also
observ
trend
splenic
donor
alloactiv
cell
express
higher
level
although
integrin
import
gvhd
pathogenesi
previous
shown
cell
caus
sustain
decreas
acut
system
intestin
gvhd
differenti
express
integrin
cell
almost
certainli
one
part
regul
target
organ
gvhd
inde
donor
alloactiv
cell
express
compar
level
integrin
wildtyp
cell
yet
also
found
increas
number
gut
figur
suggest
mechan
regul
donor
cell
activ
figur
may
also
contribut
regul
gvhd
target
organ
damag
moreov
recipi
cell
also
reduc
intestin
infiltr
despit
similar
integrin
express
suggest
regul
accumul
donor
cell
target
tissu
via
multipl
mechan
thu
result
donor
lymphocyt
infiltr
gvhd
target
tissu
secondari
lymphoid
tissu
must
interpret
cautious
must
influenc
cell
prolifer
retent
apoptosi
addit
traffick
although
cell
display
overal
symmetr
opposit
phenotyp
also
note
differ
cell
primarili
show
decreas
prolifer
wherea
cell
show
chang
prolifer
also
traffick
activ
differ
may
due
model
wt
cell
briefli
transient
upregul
activ
consequ
cell
miss
transient
cell
constitut
overexpress
furthermor
cell
effect
insensit
ligand
interact
cell
overexpress
protein
may
increas
fratern
interact
donor
cell
may
necessarili
experi
increas
interact
donor
bm
host
hematopoiet
nonhematopoiet
compon
differ
may
explain
activ
traffick
phenotyp
directli
oppos
interest
note
gvt
experi
recipi
cell
significantli
improv
surviv
challeng
lymphoma
renal
cell
carcinoma
although
lymphoma
renal
cell
carcinoma
express
cell
uniformli
express
high
level
subset
renca
cell
show
somewhat
lower
express
inde
number
hematolog
tumor
includ
leukemia
mastocytoma
myeloid
leukemia
express
substanti
level
data
shown
wherea
solid
tumor
mous
breast
epitheli
cancer
colon
tumor
normal
express
lower
even
minim
level
similar
lower
level
express
found
renca
shown
therefor
one
possibl
gvt
activ
cell
neg
regul
tumor
express
high
level
less
import
tumor
express
low
level
subset
cell
first
place
howev
renca
gvt
model
system
found
primarili
liver
lesser
extent
lung
sinc
donor
allograft
cell
show
decreas
number
donor
alloreact
cell
liver
compar
wildyp
gvhd
experi
figur
interpret
gvt
activ
renca
respect
cell
must
also
consid
aspect
biolog
conclus
result
show
donor
cell
allobmt
recipi
control
prolifer
activ
traffick
donor
alloreact
cell
sensit
gastrointestin
tissu
irradi
consequ
may
repres
viabl
target
reduc
radiationassoci
gastrointestin
toxic
control
gvhd
gvt
activ
allobmt
anim
protocol
approv
memori
sloankett
cancer
center
mskcc
institut
anim
care
use
committe
protocol
balbc
mice
obtain
jackson
laboratori
bar
harbor
balbc
mice
mice
gener
mcgill
univers
balbc
harlan
montreal
quebec
canada
maintain
memori
sloankett
cancer
center
mice
use
week
old
bm
cell
remov
femur
tibia
celldeplet
tcd
lowtoxm
rabbit
complement
cedarlan
laboratori
hornbi
canada
enrich
splenic
cell
obtain
nylon
wool
column
passag
cell
resuspend
dmem
inject
lethal
irradi
recipi
day
total
bodi
irradi
sourc
split
dose
hour
apart
purifi
splenic
cell
incub
cfse
invitrogen
carlsbad
ca
concentr
pb
cellsml
minut
wash
twice
pb
resuspend
dmem
infus
intraven
lethal
irradi
allogen
recipi
splenocyt
recipi
harvest
vari
time
point
analyz
fac
describ
surviv
monitor
daili
mice
score
weekli
clinic
paramet
weight
postur
activ
level
fur
ruffl
skin
lesion
scale
clinic
gvhd
score
gener
summat
criteria
score
mice
score
greater
consid
moribund
euthan
small
larg
bowel
liver
skin
assess
expert
blind
fashion
organ
preserv
formalin
transfer
ethanol
embed
paraffin
section
stain
hematoxylin
eosin
score
semiquantit
score
system
bowel
liver
score
differ
paramet
associ
gvhd
detail
tabl
skin
evalu
number
apoptot
epidermi
via
termin
deoxynucleotid
transferas
dutp
nick
end
label
tunel
histopatholog
score
median
fluoresc
intens
cell
count
compar
group
use
nonparametr
unpair
mannwhitney
u
test
mantelcox
logrank
test
use
surviv
data
addit
method
describ
method
